Study Evaluating Mitoxantrone in Multiple Sclerosis
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to show the dose-response relationship of three doses of
mitoxantrone with regard to efficacy in patients with secondary progressive multiple
sclerosis and to show the safety and tolerability of mitoxantrone in these patients.